Literature DB >> 1951592

Treatment of infectious scleritis and keratoscleritis.

M G Reynolds1, E Alfonso.   

Abstract

We reviewed 28 cases of culture-proven infectious scleritis and keratoscleritis to clarify the role of an operation in this disorder. Surgical management in 11 patients with keratoscleritis included cryotherapy, five; penetrating corneal-scleral graft, two; lamellar corneoscleral graft, two; and tectonic penetrating keratoplasty, two; in addition to intensive fortified antibiotic eyedrops. Eight patients with keratoscleritis were treated medically only with intensive fortified frequent antibiotic eyedrops, one; intensive instilled plus intravenous antibiotics, three; and instilled, intravenous, and subconjunctival antibiotics, four. Seven of eight patients treated with antibiotics alone and two of 11 patients who received surgical intervention in addition to antibiotics eventually required evisceration or enucleation of the eye. These results suggest that cryotherapy, lamellar or penetrating corneoscleral graft, in addition to intensive antibiotic therapy, may improve the outcome of patients with infectious keratoscleritis. Five eyes with isolated scleritis without corneal involvement were treated with conjunctival recession and cryotherapy in addition to aggressive antibiotics, and four were treated with antibiotics alone. The infections of these nine patients resolved.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1951592     DOI: 10.1016/s0002-9394(14)76856-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  24 in total

1.  Clinical experiences of infectious scleral ulceration: a complication of pterygium operation.

Authors:  C P Lin; M H Shih; M C Tsai
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

2.  Infectious Pseudomonas and Bipolaris scleritis following history of pterygium surgery.

Authors:  Ashkan M Abbey; Nisha V Shah; Richard K Forster; Leejee H Suh
Journal:  Indian J Ophthalmol       Date:  2016-09       Impact factor: 1.848

3.  Excisional keratectomy combined with focal cryotherapy and amniotic membrane inlay for recalcitrant filamentary fungal keratitis: A retrospective comparative clinical data analysis.

Authors:  Yingxin Chen; Minghong Gao; Joshua K Duncan; Di Ran; Denise J Roe; Michael W Belin; Mingwu Wang
Journal:  Exp Ther Med       Date:  2016-09-13       Impact factor: 2.447

4.  Haemophilus influenzae associated scleritis.

Authors:  S O Sykes; C Riemann; C I Santos; D M Meisler; C Y Lowder; J P Whitcher; E T Cunningham
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

5.  Second report of a Nocardia beijingensis infection in the United States: nodular scleritis with in vitro imipenem resistance.

Authors:  Andres Gonzalez; Eric Jennings; Sasha Vaziri; Anthony T Yachnis; Anup Kubal
Journal:  Digit J Ophthalmol       Date:  2016-08-10

6.  Interventions and Outcomes in Patients with Infectious Pseudomonas scleritis: A 10-Year Perspective.

Authors:  Sumayya Ahmad; Michelle Lopez; Marwan Attala; Anat Galor; Natalie A Stanciu; Darlene Miller; Leejee Suh; Thomas Albini; Victor L Perez; Carol L Karp; Janet L Davis; Eduardo Alfonso; Richard K Forster; Guillermo Amescua
Journal:  Ocul Immunol Inflamm       Date:  2017-10-17       Impact factor: 3.070

7.  Management and outcome of microbial anterior scleritis.

Authors:  Matthew A Cunningham; Jamie K Alexander; Alice Y Matoba; Dan B Jones; Kirk R Wilhemus
Journal:  Cornea       Date:  2011-09       Impact factor: 2.651

8.  Infectious scleritis mimicking severe ocular inflammation: atypical initial presentation.

Authors:  Somasheila I Murthy; Alok Sati; Virender Sangwan
Journal:  BMJ Case Rep       Date:  2013-02-20

9.  Infectious scleritis: report of four cases.

Authors:  M Sainz de la Maza; R K Hemady; C S Foster
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

10.  Corneoscleral transplantation for end stage corneal disease.

Authors:  L W Hirst; G A Lee
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.